Novel CD28-Responsive Enhancer Activated by CREB/ATF and AP-1 Families in the Human Interleukin-2 Receptor α-Chain Locus

REFERENCES

• Agarwal, S., and A. Rao. 1998. Long-range transcriptional regulation of cytokine gene expression. Curr. Opin. Immunol. 10:345–352.
   PubMed Web of Science ®Google Scholar
• Algarte, M., P. Lecine, R. Costello, A. Plet, D. Olive, and J. Imbert. 1995. In vivo regulation of interleukin-2 receptor alpha gene transcription by the coordinated binding of constitutive and inducible factors in human primary T-cells. EMBO J. 14:5060–5072.
   PubMedGoogle Scholar
• Barton, K., N. Muthusamy, M. Chanyangam, C. Fischer, C. Clendenin, and J. M. Leiden. 1996. Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB. Nature 379:81–85.
   PubMedGoogle Scholar
• Bernal-Mizrachi, E., B. Wice, H. Inoue, and M. A. Permutt. 2000. Activation of serum response factor (SRF) in the depolarization induction of Egr-1 transcription in pancreatic islet β-cells. J. Biol. Chem. 275:25681–25689.
   PubMedGoogle Scholar
• Butscher, W. G., C. Powers, M. Olive, C. Vinson, and K. Gardner. 1998. Coordinate transactivation of the interleukin-2 CD28 response element by c-Rel and ATF-1/CREB2. J. Biol. Chem. 273:552–560.
   PubMedGoogle Scholar
• Cerdan, C., Y. Martin, H. Brailly, M. Courcoul, S. Flavetta, R. Costello, C. Mawas, F. Birg, and D. Olive. 1991. IL-1 alpha is produced by T lymphocytes activated via the CD2 plus CD28 pathways. J. Immunol. 146:560–564.
   PubMedGoogle Scholar
• Cerdan, C., Y. Martin, M. Courcoul, H. Brailly, C. Mawas, F. Birg, and D. Olive. 1992. Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation. J. Immunol. 149:2255–2261.
   PubMed Web of Science ®Google Scholar
• Chambers, C. A., and J. P. Allison. 1999. Costimulatory regulation of T cell function. Curr. Opin. Cell Biol. 11:203–210.
   PubMed Web of Science ®Google Scholar
• Civil, A., M. Geerts, L. A. Aarden, and C. L. Verweij. 1992. Evidence for a role of CD28RE as a response element for distinct mitogenic T cell activation signals. Eur. J. Immunol. 22:3041–3043.
   PubMed Web of Science ®Google Scholar
• Civil, A., I. Rensink, L. A. Aarden, and C. L. Verweij. 1999. Functional disparity of distinct CD28 response elements toward mitogenic responses. J. Biol. Chem. 274:34369–34374.
   PubMedGoogle Scholar
• Cockerill, P. N., M. F. Shannon, A. G. Bert, G. R. Ryan, and M. A. Vadas. 1993. The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer. Proc. Natl. Acad. Sci. USA 90:2466–2470.
   PubMed Web of Science ®Google Scholar
• Costa, J. J., J. M. Keffer, J. P. Goff, and D. D. Metcalfe. 1992. Aphidicolin-induced proliferative arrest of murine mast cells: morphological and biochemical changes are not accompanied by alterations in cytokine gene induction. Immunology 76:413–421.
   PubMedGoogle Scholar
• Costello, R., C. Lipcey, M. Algarte, C. Cerdan, P. A. Baeuerle, D. Olive, and J. Imbert. 1993. Activation of primary human T-lymphocytes through CD2 plus CD28 adhesion molecules induces long-term nuclear expression of NF-κB. Cell Growth Differ. 4:329–339.
   PubMedGoogle Scholar
• Cross, S. L., M. Feinberg, J. B. Wolf, N. J. Holbrook, F. Wong-Staal, and W. J. Leonard. 1987. Regulation of the human interleukin-2 receptor alpha chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I. Cell 49:47–56.
   PubMed Web of Science ®Google Scholar
• De Cesare, D., and P. Sassone-Corsi. 2000. Transcriptional regulation by cyclic AMP-responsive factors. Prog. Nucleic Acid Res. Mol. Biol. 64:343–369.
   PubMedGoogle Scholar
• Fraser, J. D., B. A. Irving, G. R. Crabtree, and A. Weiss. 1991. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251:313–316.
   PubMed Web of Science ®Google Scholar
• Fraser, J. D., and A. Weiss. 1992. Regulation of T-cell lymphokine gene transcription by the accessory molecule CD28. Mol. Cell. Biol. 12:4357–4363.
   PubMedGoogle Scholar
• Gerondakis, S., R. Grumont, I. Rourke, and M. Grossmann. 1998. The regulation and roles of Rel/NF-κB transcription factors during lymphocyte activation. Curr. Opin. Immunol. 10:353–359.
   PubMed Web of Science ®Google Scholar
• Ghosh, P., T. H. Tan, N. R. Rice, A. Sica, and H. A. Young. 1993. The interleukin 2 CD28-responsive complex contains at least three members of the NFκB family: c-Rel, p50, and p65. Proc. Natl. Acad. Sci. USA 90:1696–1700.
   PubMedGoogle Scholar
• Gonzalez, G. A., and M. R. Montminy. 1989. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59:675–680.
   PubMed Web of Science ®Google Scholar
• Hagiwara, M., P. Brindle, A. Harootunian, R. Armstrong, J. Rivier, W. Vale, R. Tsien, and M. R. Montminy. 1993. Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A. Mol. Cell. Biol. 13:4852–4859.
   PubMed Web of Science ®Google Scholar
• Hagmeyer, B. M., P. Angel, and H. van Dam. 1995. Modulation of AP-1/ATF transcription factor activity by the adenovirus-ElA oncogene products. Bioessays 17:621–629.
   PubMedGoogle Scholar
• Herzig, R. P., S. Scacco, and R. C. Scarpulla. 2000. Sequential serum-dependent activation of CREB and NRF-1 leads to enhanced mitochondrial respiration through the induction of cytochrome c. J. Biol. Chem. 275:13134–13141.
   PubMed Web of Science ®Google Scholar
• Hsueh, Y. P., H. E. Liang, S. Y. Ng, and M. Z. Lai. 1997. CD28-costimulation activates cyclic AMP-responsive element-binding protein in T lymphocytes. J. Immunol. 158:85–93.
   PubMedGoogle Scholar
• John, S., R. B. Reeves, J. X. Lin, R. Child, J. M. Leiden, C. B. Thompson, and W. J. Leonard. 1995. Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG- I(Y), and NF-κB family proteins. Mol. Cell. Biol. 15:1786–1796.
   PubMed Web of Science ®Google Scholar
• John, S., C. M. Robbins, and W. J. Leonard. 1996. An IL-2 response element in the human IL-2 receptor alpha chain promoter is a composite element that binds Stat5, Elf-1, HMG-I(Y) and a GATA family protein. EMBO J. 15:5627–5635.
   PubMed Web of Science ®Google Scholar
• June, C. H., J. A. Bluestone, L. M. Nadler, and C. B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321–331.
   PubMedGoogle Scholar
• Kanamori, H., N. Suzuki, H. Siomi, T. Nosaka, A. Sato, H. Sabe, M. Hatanaka, and T. Honjo. 1990. HTLV-1 p27rex stabilizes human interleukin-2 receptor chain mRNA. EMBO J. 9:4161–4166.
   PubMed Web of Science ®Google Scholar
• Kempiak, S. J., T. S. Hiura, and A. E. Nel. 1999. The Jun kinase cascade is responsible for activating the CD28 response element of the IL-2 promoter: proof of cross-talk with the I kappa B kinase cascade. J. Immunol. 162:3176–3187.
   PubMedGoogle Scholar
• Kuang, A. A., K. D. Novak, S. M. Kang, K. Bruhn, and M. J. Lenardo. 1993. Interaction between NF-kappa B and serum response factor-binding elements activates an interleukin-2 receptor alpha-chain enhancer specifically in T lymphocytes. Mol. Cell. Biol. 13:2536–2545.
   PubMedGoogle Scholar
• Lai, J. H., G. Horvath, J. Subleski, J. Bruder, P. Ghosh, and T. H. Tan. 1995. RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter. Mol. Cell. Biol. 15:4260–4271.
   PubMed Web of Science ®Google Scholar
• Lecine, P., M. Algarte, P. Rameil, C. Beadling, P. Bucher, M. Nabholz, and J. Imbert. 1996. Elf-1 and Stat5 bind to a critical element in a new enhancer of the human interleukin-2 receptor alpha gene. Mol. Cell. Biol. 16:6829–6840.
   PubMed Web of Science ®Google Scholar
• Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233–258.
   PubMed Web of Science ®Google Scholar
• Leonard, W. J., M. Kronke, N. J. Pfeffer, J. M. Depper, and W. C. Greene. 1985. Interleukin 2 receptor gene expression in normal human T lymphocytes. Proc. Natl. Acad. Sci. USA 82:6281–6285.
   PubMed Web of Science ®Google Scholar
• Lin, B. B., S. L. Cross, N. F. Halden, D. G. Roman, M. B. Toledano, and W. J. Leonard. 1990. Delineation of an enhancer like positive regulatory element in the interleukin-2 receptor alpha-chain gene. Mol. Cell. Biol. 10:850–853.
   PubMedGoogle Scholar
• Linsley, P. S., and J. A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191–212.
   PubMed Web of Science ®Google Scholar
• Liu, F., M. A. Thompson, S. Wagner, M. E. Greenberg, and M. R. Green. 1993. Activating transcription factor-1 can mediate Ca(2+)− and cAMP-inducible transcriptional activation. J. Biol. Chem. 268:6714–6720.
   PubMedGoogle Scholar
• Li-Weber, M., M. Giasi, and P. H. Krammer. 1998. Involvement of Jun and Rel proteins in up-regulation of interleukin-4 gene activity by the T cell accessory molecule CD28. J. Biol. Chem. 273:32460–32466.
   PubMed Web of Science ®Google Scholar
• Maggirwar, S. B., E. W. Harhaj, and S. C. Sun. 1997. Regulation of the interleukin-2 CD28-responsive element by NF-ATp and various NF-κB/Rel transcription factors. Mol. Cell. Biol. 17:2605–2614.
   PubMed Web of Science ®Google Scholar
• Mari, B., V. Imbert, N. Belhacene, D. F. Far, J. F. Peyron, J. Pouyssegur, E. Van Obberghen-Schilling, B. Rossi, and P. Auberger. 1994. Thrombin and thrombin receptor agonist peptide induce early events of T cell activation and synergize with TCR cross-linking for CD69 expression and interleukin 2 production. J. Biol. Chem. 269:8517–8523.
   PubMed Web of Science ®Google Scholar
• Nelson, B. H., and D. M. Willerford. 1998. Biology of the interleukin-2 receptor. Adv. Immunol. 70:1–81.
   PubMed Web of Science ®Google Scholar
• Nichols, M., F. Weih, W. Schmid, C. DeVack, E. Kowenz-Leutz, B. Luckow, M. Boshart, and G. Schütz. 1992. Phosphorylation of CREB affects its binding to high and low affinity sites: implications of cAMP induced gene transcription. EMBO J. 11:3337–3346.
   PubMed Web of Science ®Google Scholar
• Nunes, J., S. Klasen, M. D. Franco, C. Lipcey, C. Mawas, M. Bagnasco, and D. Olive. 1993. Signalling through CD28 T-cell activation pathway involves an inositolphospholipid-specific phospholipase C activity. Biochem. J. 293:835–842.
   PubMedGoogle Scholar
• Pages, F., M. Ragueneau, S. Klasen, M. Battifora, D. Couez, R. Sweet, A. Truneh, S. G. Ward, and D. Olive. 1996. Two distinct intracytoplasmic regions of the T-cell adhesion molecule CD28 participate in phosphatidylinositol 3-kinase association. J. Biol. Chem. 271:9403–9409.
   PubMedGoogle Scholar
• Parekh, B. S., and T. Maniatis. 1999. Virus infection leads to localized hyperacetylation of histones H3 and H4 at the IFN-beta promoter. Mol. Cell 3:125–129.
   PubMed Web of Science ®Google Scholar
• Pennypacker, K. R.. 1995. AP-1 transcription factor complexes in CNS disorders and development. J. Fla. Med. Assoc. 82:551–554.
   PubMedGoogle Scholar
• Pierce, J. W., C. A. Jamieson, J. L. Ross, and R. Sen. 1995. Activation of IL-2 receptor alpha-chain gene by individual members of the rel oncogene family in association with serum response factor. J. Immunol. 155:1972–1980.
   PubMedGoogle Scholar
• Plet, A., X. Huet, M. Algarte, J. Rech, J. Imbert, A. Philips, and J. M. Blanchard. 1997. Relief of cyclin A gene transcriptional inhibition during activation of human primary T lymphocytes via CD2 and CD28 adhesion molecules. Oncogene 14:2575–2583.
   PubMedGoogle Scholar
• Quinn, P. G.. 1993. Distinct activation domains within cAMP response element-binding protein (CREB) mediate basal and cAMP-stimulated transcription. J. Biol. Chem. 268:16999–17009.
   PubMed Web of Science ®Google Scholar
• Rameil, P., P. Lecine, J. Ghysdael, F. Gouilleux, B. Kahn-Perles, and J. Imbert. 2000. IL-2 and long-term T cell activation induce physical and functional interactions between STAT5 and ETS transcription factors in human T cells. Oncogene 19:2086–2097.
   PubMedGoogle Scholar
• Roifman, C. M., and H. K. Dadi. 2000. Human interleukin-2 receptor alpha deficiency. Pediatr. Res. 48:6–11.
   PubMed Web of Science ®Google Scholar
• Rudd, C. E.. 1996. Upstream-downstream: CD28 cosignaling pathways and T cell function. Immunity 4:527–534.
   PubMedGoogle Scholar
• Schorle, H., T. Holtschke, T. Hunig, A. Schimpl, and I. Horak. 1991. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352:621–624.
   PubMed Web of Science ®Google Scholar
• Shapiro, V. S., K. E. Truitt, J. B. Imboden, and A. Weiss. 1997. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites. Mol. Cell. Biol. 17:4051–4058.
   PubMed Web of Science ®Google Scholar
• Sheng, M., M. A. Thompson, and M. E. Greenberg. 1991. CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 252:1427–1430.
   PubMed Web of Science ®Google Scholar
• Siefken, R., S. Klein-Hessling, E. Serfling, R. Kurrle, and R. Schwinzer. 1998. A CD28-associated signaling pathway leading to cytokine gene transcription and T cell proliferation without TCR engagement. J. Immunol. 161:1645–1651.
   PubMedGoogle Scholar
• Soldaini, E., M. Pla, F. Beermann, E. Espel, P. Corthesy, S. Barange, G. A. Waanders, H. R. MacDonald, and M. Nabholz. 1995. Mouse interleukin-2 receptor alpha gene expression. Delimitation of cis-acting regulatory elements in transgenic mice and by mapping of DNAse-I hypersensitive sites. J. Biol. Chem. 270:10733–10742.
   PubMedGoogle Scholar
• Sperisen, P., S. M. Wang, E. Soldaini, M. Pla, C. Rusterholz, P. Bucher, P. Corthesy, P. Reichenbach, and M. Nabholz. 1995. Mouse interleukin-2 receptor alpha gene expression—Interleukin-1 and interleukin-2 control transcription via distinct cis-acting elements. J. Biol. Chem. 270:10743–10753.
   PubMedGoogle Scholar
• Struthers, R. S., W. W. Vale, C. Arias, P. E. Sawchenko, and M. R. Montminy. 1991. Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant. Nature 350:622–624.
   PubMedGoogle Scholar
• Su, B., E. Jacinto, M. Hibi, T. Kallunki, M. Karin, and Y. Ben-Neriah. 1994. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77:727–736.
   PubMed Web of Science ®Google Scholar
• Taniguchi, T., and Y. Minami. 1993. The IL-2/IL-2 receptor system: a current overview. Cell 73:5–8.
   PubMed Web of Science ®Google Scholar
• Verweij, C. L., M. Geerts, and L. A. Aarden. 1991. Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-κB-like response element. J. Biol. Chem. 266:14179–14182.
   PubMedGoogle Scholar
• Waeber, G., and J. F. Habener. 1991. Nuclear translocation and DNA recognition signals colocalized within the bZIP domain of cyclic adenosine 3′,5′-monophosphate response element-binding protein CREB. Mol. Endocrinol. 5:1431–1438.
   PubMedGoogle Scholar
• Ward, S. G.. 1996. CD28: a signalling perspective. Biochem. J. 318:361–377.
   PubMed Web of Science ®Google Scholar
• Wechsler, A. S., M. C. Gordon, U. Dendorfer, and K. P. LeClair. 1994. Induction of IL-8 expression in T cells uses the CD28 costimulatory pathway. J. Immunol. 153:2515–2523.
   PubMedGoogle Scholar
• Willerford, D. M., J. Chen, J. A. Ferry, L. Davidson, A. Ma, and F. W. Alt. 1995. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521–530.
   PubMed Web of Science ®Google Scholar
• Wu, C.. 1989. Analysis of hypersensitive sites in chromatin. Methods Enzymol. 170:269–289.
   PubMedGoogle Scholar